Trial Profile
Feasibility study of Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Primary Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2018
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide; Doxorubicin; Epirubicin; Fluorouracil
- Indications Breast cancer
- Focus Therapeutic Use
- 12 Dec 2015 Status changed from recruiting to completed as per Results presented at the 9th European Breast Cancer Conference
- 03 Jun 2011 New trial record